Non-cardiogenic pulmonary edema, acute respiratory distress syndrome
Authors:
Hana Skalická; prof. MUDr. Jan Bělohlávek, Ph.D.
Authors place of work:
II. interní klinika – klinika kardiologie a angiologie 1. LF UK a VFN, Praha
Published in the journal:
Čas. Lék. čes. 2015; 154: 273-279
Category:
Review Article
Summary
Non-cardiogenic pulmonary edema is a clinical syndrome manifested by rapidly progressive respiratory distress leading, without therapy, to severe respiratory insufficiency and subsequent multiorgan failure. The pathophysiological causes are: the change in the pressure gradients in the pulmonary capillaries, the impaired membrane permeability of the alveolocapillary in the lungs, and impaired lymphatic drainage. Unlike in cardiogenic pulmonary edema, cardiac disease is not a cause, and there is no increase in wedge pressure (< 18 mm Hg). The aetiological base is diverse and includes more clinical pathological factors. The diagnosis and evaluation are usually very difficult due to the rapidly deteriorating clinical condition of the patients. A decisive, quick and comprehensive approach, using all available invasive and non-invasive methods is necessary. The basic steps of treatment are: the use of different types of ventilatory support in order to achieve adequate oxygenation, dealing with possible hemodynamic instability, and, when needed, other specific procedures. It is always important to keep in mind that this is a very serious condition with a high mortality rate. And there is a need for fast and efficient access to the best specialized clinic.
Keywords:
non-cardiogenic pulmonary edema – acute respiratory distress syndrome – protective ventilatory support – extracorporeal membrane oxygenation
Zdroje
1. Braunwald E. Heart disease: a textbook of cardiovascular medicine. 4th ed. Philadelphia: Saunders 1992.
2. Burnham EL, et al. The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance. Eur Respir J 2014; 43(1): 276–285.
3. Fowler AA, et al. Adult respiratory distress syndrome: risk with common predispositions. Ann Intern Med 1983; 98(5 Pt 1): 593–597.
4. Pepe PE, et al. Early prediction of the adult respiratory distress syndrome by a simple scoring method. Ann Emerg Med 1983; 12(12): 749–755.
5. Peek GJ, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009; 374(9698): 1351–1363.
6. Stein L, et al. Pulmonary edema during volume infusion. Circulation 1975; 52(3): 483–489.
7. Bhaskar B, Fraser JF. Negative pressure pulmonary edema revisited: Pathophysiology and review of management. Saudi J Anaesth 2011; 5(3): 308–313.
8. Edoote Y, Bar-Lavie Y. Non-cardiogenic pulmonary edema following upper airway obstruction in adults. Harefuah 2000; 139(9–10): 385–388.
9. Brambrink AM, Dick WF. Neurogenic pulmonary edema. Pathogenesis, clinical picture and therapy. Anaesthesist 1997; 46(11): 953–963.
10. Steinberg AD, Karliner JS. The clinical spectrum of heroin pulmonary edema. Arch Intern Med 1968; 122(2): 122–127.
11. Goldsmith SR, Steinberg P. Noncardiogenic pulmonary edema induced by nonionic low-osmolality radiographic contrast media. J Allergy Clin Immunol 1995; 96(5 Pt 1): 698–699.
12. Ladner E, et al. High altitude pulmonary edema at a medium height. A case report. Anaesthesist 1994; 43(3): 183–186.
13. Force ADT, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012; 307(23): 2526–2533.
14. Colice GL. Detecting the presence and cause of pulmonary edema. Postgrad Med 1993; 93(6): 161–166, 169–170.
15. Milne EN, et al. The radiologic distinction of cardiogenic and noncardiogenic edema. AJR Am J Roentgenol 1985; 144(5): 879–894.
16. Grieser C, et al. Computed tomography findings from patients with ARDS due to Influenza A (H1N1) virus-associated pneumonia. Eur J Radiol 2012; 81(2): 389–394.
17. Gattinoni L, Pesenti A. The concept of „baby lung“. Intensive Care Med 2005; 31(6): 776–784.
18. Lichtenstein DA. BLUE-protocol and FALLS-protocol: two applications of lung ultrasound in the critically ill. Chest 2015; 147(6): 1659–1670.
19. Al Deeb M, et al. Point-of-care ultrasonography for the diagnosis of acute cardiogenic pulmonary edema in patients presenting with acute dyspnea: a systematic review and meta-analysis. Acad Emerg Med 2014; 21(8): 843–852.
20. Corradi F, Brusasco C, Pelosi P. Chest ultrasound in acute respiratory distress syndrome. Curr Opin Crit Care 2014; 20(1): 98–103.
21. Rubenfeld, GD. Who cares about preventing acute respiratory distress syndrome? Am J Respir Crit Care Med, 2015; 191(3): 255–260.
22. Villar J, Kacmarek RM. The American-European Consensus Conference definition of the acute respiratory distress syndrome is dead, long live positive end-expiratory pressure! Med Intensiva 2012; 36(8): 571–575.
23. Petrucci N, Iacovelli W. Lung protective ventilation strategy for the acute respiratory distress syndrome. Cochrane Database Syst Rev 2007; (3): CD003844.
24. National Heart L, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006; 354(24): 2564–2575.
25. Silva PL, Pelosi P, Rocco PR. Fluids in acute respiratory distress syndrome: pros and cons. Curr Opin Crit Care 2014; 20(1): 104–112.
26. Spieth PM, Zhang H. Pharmacological therapies for acute respiratory distress syndrome. Curr Opin Crit Care 2014; 20(1): 113–121.
27. Petty TL, Fowler AA. 3rd, Another look at ARDS. Chest 1982; 82(1): 98–104.
28. Adhikari NK, Scales DC. Corticosteroids for acute respiratory distress syndrome. BMJ 2008; 336(7651): 969–970.
29. Peter JV, et al. Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis. BMJ 2008; 336(7651): 1006–1009.
30. Willson DF, et al. The Adult Calfactant in Acute Respiratory Distress Syndrome Trial. Chest 2015; 148(2): 356–364.
31. Fuller BM, et al. The use of inhaled prostaglandins in patients with ARDS: a systematic review and meta-analysis. Chest 2015; 147(6): 1510–1522.
32. Hraiech S, Dizier S, Papazian L. The use of paralytics in patients with acute respiratory distress syndrome. Clin Chest Med 2014; 35(4): 753–763.
33. McAuley DF, et al. Simvastatin in the acute respiratory distress syndrome. N Engl J Med 2014; 371(18): 1695–1703.
34. Maron-Gutierrez T, et al. Cell-based therapies for the acute respiratory distress syndrome. Curr Opin Crit Care 2014; 20(1): 122–131.
35. Liu KD, et al. Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-severe acute respiratory distress syndrome. Ann Intensive Care 2014; 4: 22.
36. Gotts JE, Matthay MA. Endogenous and exogenous cell-based pathways for recovery from acute respiratory distress syndrome. Clin Chest Med 2014; 35(4): 797–809.
37. Abroug F, et al. The effect of prone positioning in acute respiratory distress syndrome or acute lung injury: a meta-analysis. Areas of uncertainty and recommendations for research. Intensive Care Med 2008; 34(6): 1002–1011.
38. Alsaghir AH, Martin CM. Effect of prone positioning in patients with acute respiratory distress syndrome: a meta-analysis. Crit Care Med 2008; 36(2): 603–609.
39. Mora-Arteaga JA, Bernal-Ramirez OJ, Rodriguez SJ. The effects of prone position ventilation in patients with acute respiratory distress syndrome. A systematic review and metaanalysis. Med Intensiva 2015; 39(6): 352–365.
40. Fernandez R, et al. Prone positioning in acute respiratory distress syndrome: a multicenter randomized clinical trial. Intensive Care Med 2008; 34(8): 1487–1491.
41. Romero CM, et al. Extended prone position ventilation in severe acute respiratory distress syndrome: a pilot feasibility study. J Crit Care 2009; 24(1): 81–88.
42. Beitler JR, et al. Prone positioning reduces mortality from acute respiratory distress syndrome in the low tidal volume era: a meta-analysis. Intensive Care Med 2014; 40(3): 332–341.
43. Naorungroj T, et al. High-frequency oscillatory ventilation for patients during exudative phase of severe ARDS. J Med Assoc Thai 2015; 98(4): 343–351.
44. Goffi A, Ferguson ND. High-frequency oscillatory ventilation for early acute respiratory distress syndrome in adults. Curr Opin Crit Care 2014; 20(1): 77–85.
45. Hayes D, Jr, et al. Extracorporeal life support for acute respiratory distress syndromes. Ann Thorac Med 2013; 8(3): 133–141.
46. Del Sorbo L, Cypel M, Fan E. Extracorporeal life support for adults with severe acute respiratory failure. Lancet Respir Med 2014; 2(2): 154–164.
47. Biderman P, et al. Extracorporeal life support in patients with multiple injuries and severe respiratory failure: a single-center experience? J Trauma Acute Care Surg 2013; 75(5): 907–912.
48. Zangrillo A, et al. Extracorporeal membrane oxygenation (ECMO) in patients with H1N1 influenza infection: a systematic review and meta-analysis including 8 studies and 266 patients receiving ECMO. Crit Care 2013; 17(1): R30.
49. Management and Writing Committee (Australia, New Zealand). Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA 2009; 302(17): 1888–1895.
50. Turner DA, et al. Extracorporeal membrane oxygenation for severe refractory respiratory failure secondary to 2009 H1N1 influenza A. Respir Care 2011; 56(7): 941–946.
51. Zampieri FG, et al. Extracorporeal membrane oxygenation for severe respiratory failure in adult patients: a systematic review and meta-analysis of current evidence. J Crit Care 2013; 28(6): 998–1005.
52. Noah MA, et al. Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1). JAMA 2011; 306(15): 1659–1668.
53. Nelson J, Cairns B, Charles A. Early extracorporeal life support as rescue therapy for severe acute respiratory distress syndrome after inhalation injury. J Burn Care Res 2009; 30(6): 1035–1038.
Štítky
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistČlánok vyšiel v časopise
Journal of Czech Physicians
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Spasmolytic Effect of Metamizole
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
- Metamizole in perioperative treatment in children under 14 years – results of a questionnaire survey from practice
Najčítanejšie v tomto čísle
- Mountain sickness
- Non-cardiogenic pulmonary edema, acute respiratory distress syndrome
- Chronic heart failure
- Analysis of the relationship of heavy/light chain pairs of immunoglobulin (Hevylite™) to the results of gel electrophoresis and nefelometric examination of serum proteins at the time of multiple myeloma diagnosis